Literature DB >> 6459340

Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin.

F H Derkx, M P Schalekamp, B Bouma, C Kluft, M A Schalekamp.   

Abstract

Activation of prorenin in the neutral phase after pH 3.3 dialysis of human plasma depends on clotting factor XII-initiated prekallikrein to kallikrein conversion. Acid dialysis may be necessary for destroying kallikrein inhibitors or rendering prorenin susceptible to attack by kallikrein. If the latter possibility proves true, it is difficult to see how the factor XII-kallikrein pathway could activate prorenin in vivo. Plasma prorenin was therefore separated from active renin and from the protease inhibitors alpha 2-macroglobulin, C1-inactivator, alpha 1-antitrypsin, inter-alpha-trypsin inhibitor, and antithrombin III by gel filtration on Sephadex G-100 and affinity chromatography on Blue Sepharose CL-6B at neutral pH. The resulting prorenin preparation could be activated at pH 7.5 by highly purified human plasma kallikrein, which was prepared from prekallikrein by activation with active factor XII fragment beta-factor XII a. Activation proceeded at 4 and 37 C at a kallikrein concentration of 2 micrograms/ml, which is approximately 5% of the prekallikrein concentration in normal plasma. It appears that an acid-induced conformational change of the prorenin molecule is not required for its activation by plasma kallikrein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6459340     DOI: 10.1210/jcem-54-2-343

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  Mapping the human plasma proteome by SCX-LC-IMS-MS.

Authors:  Xiaoyun Liu; Stephen J Valentine; Manolo D Plasencia; Sarah Trimpin; Stephen Naylor; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2007-04-24       Impact factor: 3.109

2.  Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system.

Authors:  Nilima Biswas; Adam X Maihofer; Saiful Anam Mir; Fangwen Rao; Kuixing Zhang; Srikrishna Khandrika; Manjula Mahata; Ryan S Friese; C Makena Hightower; Sushil K Mahata; Dewleen G Baker; Caroline M Nievergelt; Sucheta M Vaingankar; Daniel T O'Connor
Journal:  BMC Med Genet       Date:  2016-03-11       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.